GMA
BMY icon

Glassy Mountain Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Glassy Mountain Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-43,772
Closed -$3.2M – 71
2022
Q1 		$3.2M Buy
43,772
+1,358
+3% +$91.2K 1.64% 21
2021
Q4 		$2.64M Buy
+42,414
New +$2.49M 1.36% 28

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Glassy Mountain Advisors's BMY Position: Q2 2022 in Review

Glassy Mountain Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 43,772 shares — an estimated $3.2M sold.

Glassy Mountain Advisors first reported a position in BMY in Q4 2021 and held it in 2 quarters. The position peaked at $3.2M in Q1 2022. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Glassy Mountain Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
  • Glassy Mountain Advisors sold 43,772 Bristol-Myers Squibb shares in Q2 2022, an estimated $3.2M.
  • Glassy Mountain Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 2 quarters.
  • Glassy Mountain Advisors's Bristol-Myers Squibb position peaked at $3.2M in Q1 2022.
  • 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Glassy Mountain Advisors's 13F filing for Q2 2022, filed 11 Jul 2022.